CLOVER HEALTH INVESTMENTS CORP. - CLASS A COMMON

Clover Health to Report Second Quarter 2022 Financial Results on August 8, 2022

11 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Set to Join Russell 3000® Index

24 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Appoints Scott J. Leffler as Chief Financial Officer

25 May 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Reports First Quarter 2022 Financial Results

09 May 2022 16:05:01 By Nasdaq GlobeNewswire

Aric Sharp Announced as Divisional CEO of Value Based Care for Clover Health

09 May 2022 16:02:00 By Nasdaq GlobeNewswire

Clover Health to Present at Bank of America 2022 Healthcare Conference on May 11, 2022

27 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health to Report First Quarter 2022 Financial Results on May 9, 2022

11 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

15 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Hires Joseph Martin as General Counsel

14 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health to Present at Barclays 2022 Global Healthcare Conference on March 15, 2022

08 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Hires Conrad Wai as Chief Technology Officer

28 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Reports Fourth Quarter 2021 Financial Results

23 Feb 2022 16:32:55 By Nasdaq GlobeNewswire

Clover Health to Present at Citi's 2022 Virtual Healthcare Conference on February 24, 2022

10 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

25 Jan 2022 16:05:00 By Nasdaq GlobeNewswire

Clover Health Beats Expectations with Medicare Advantage Membership Growing by Over 25% at the Start of 2022

10 Jan 2022 08:45:00 By Nasdaq GlobeNewswire

Clover Health to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference on January 11, 2022

04 Jan 2022 16:05:01 By Nasdaq GlobeNewswire

Clover Health Launches New Clinical Program Targeting Chronic Kidney Disease in Partnership with Cricket Health

09 Dec 2021 09:00:02 By Nasdaq GlobeNewswire

Clover Announces Closing of Public Offering of Class A Common Stock

23 Nov 2021 13:47:42 By Nasdaq GlobeNewswire

Clover Health Investments, Corp. Announces Pricing of $300 Million Upsized Public Offering of Class A Common Stock

17 Nov 2021 21:36:47 By Nasdaq GlobeNewswire

Clover Health Investments, Corp. Announces Proposed Public Offering of Class A Common Stock

15 Nov 2021 16:19:36 By Nasdaq GlobeNewswire